Zydus Lifesciences Limited (Formerly known as ... Cadila Healthcare announced that the company has received a warning letter by the USFDA relating to its Moraiya formulation facility and Ahmedabad ...

Indian markets closed on a positive note on Monday with the 30-share Sensex gaining 454 points or 0.59 per cent to settle at ...

This complaint was first surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign ...

Stocks like SH Kelkar and Company, Ashoka Buildcon, Vodafone Idea, Bharti Airtel, Coal India, Power Grid Corporation, Nuvoco ...

The company has received a Letter of Intent from the Resolution Professional ... a US-based biopharmaceutical company wholly owned by Zydus Lifesciences, and Fortress Biotech Inc, announced ...

In September 2024, Zydus Lifesciences intimated about execution of Business ... The Company and SBL have today, i.e. 27 December 2024, executed a letter to extend the date of completion as above. In ...

Even as the global diabetes war continues to rage, Indian pharmaceutical companies are emerging from the shadows, armed with ...

Sentynl Therapeutics, an American subsidiary of India's Zydus Lifesciences, has announced that the US ... from our global network of life sciences reporters. Receive The Pharma Letter daily news ...

Zydus Wellness Ltd announced that its subsidiary, Zydus Wellness Products Ltd, has received a GST demand of Rs 56.33 crore with interest and penalties from the tax authority. The demand relates to ...

Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.

Zydus Lifesciences announced that it has entered into an agreement with CVS Caremark, a CVS Health (CVS) company, to add Zituvio, Zituvimet and Zituvimet XR tablets to its template formulary.